Session date: 
08/08/2024 - 12:20pm to 1:20pm

Presentation Title: A Drug Discovery Platform for Novel Therapeutics Against Leishmaniasis and Malaria
 

Speaker: Ravi Durvasula, MD
Professor of Medicine, Mayo Clinic College of Medicine and Science
Division Chair, Infectious Diseases
Mayo Clinic, Florida

Learning Objectives:

•Review global epidemiology of Leishmania infections
•Summarize clinical syndromes of Leishmania infections and current therapeutic options
•Discuss advanced molecular approaches for control of Leishmaniasis
•Review mandate for new therapeutics against malaria
•Discuss drug discovery efforts at Mayo Clinic

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Presenter: 
Ravi Durvasula, MD
Additional presenter: 
William Palmer, MD (moderator)
Support location: 
Minnesota

Please login or register to take this course.
Support location: 
Minnesota